Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189

INTRODUCTION: The aim of this study was to evaluate the efficacy of pemetrexed and platinum plus pembrolizumab by baseline tumor burden. METHODS: A total of 616 patients in the intention-to-treat population of the KEYNOTE-189 study were included in this analysis. Baseline tumor burden subgroups were...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadgeel, Shirish, Gray, Jhanelle E., Rizzo, Maria Teresa, Peterson, Patrick, Kim, Jong Seok, Rodríguez-Abreu, Delvys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667308/
https://www.ncbi.nlm.nih.gov/pubmed/36406000
http://dx.doi.org/10.1016/j.jtocrr.2022.100389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667308/
https://www.ncbi.nlm.nih.gov/pubmed/36406000
http://dx.doi.org/10.1016/j.jtocrr.2022.100389

Ejemplares similares